Skip to content
For laboratory research use only · Not for human consumption
Pioneer Labs

Blends / Research guide

CJC-1295 (No DAC) + Ipamorelin.

A little deeper. A clearer picture.

Two peptides with distinct research pathways. This pairing combines a modified GHRH fragment with a small growth-hormone secretagogue peptide.

For research use onlyView CJC-1295 (No DAC) + Ipamorelin sizes
Published by Pioneer LabsUpdated Sources & editorial standards

01 / Naming

DAC or No DAC: what differs.

Both forms of CJC-1295 share one 29-residue chain, Modified GRF (1–29). It is the GHRH(1–29) reference sequence with the four substitutions below, and it ends in an amidated arginine.

The DAC form adds a 30th residue: a lysine at the C-terminus that carries a maleimidopropionyl group, the attachment supplier records call DAC. The No DAC form has neither, and it is the form in this blend.

Modified GRF (1–29): the four substitutions
PositionGHRH(1–29)Modified GRF (1–29)
2AlaD-Ala
8AsnGln
15GlyAla
27MetLeu
Reference values from public records, not a Pioneer lot specification.

References: [1][3][4]

02 / Molecular architecture

A closer look at the components.

The no-DAC reference is Modified GRF (1–29), a 29-residue peptide. Ipamorelin is a pentapeptide containing nonstandard and D-amino-acid residues. Mixing them does not produce a single 34-residue molecule.

Pioneer / Reference notesComponent map
  • Modified GRF (1–29)
  • Ipamorelin · 5 residues
  • No DAC attachment
Components shown separately. This is a component list, not a chemical structure or a molecular ratio.

Reference information: [1][2][3][4][5]. Actual lot identity must be verified separately.

Two very different chain designs.

The no-DAC component is referenced as Modified GRF (1–29), while ipamorelin is a five-residue chain. Ipamorelin’s unusual residues and terminal amide illustrate why adding the residue counts is not a description of the formulation. Each molecule retains its own backbone, terminal groups and molecular mass.

Why the no-DAC qualifier matters.

The no-DAC wording distinguishes the reference from DAC-containing CJC-1295. It is an identity qualifier, not an optional display name. Comparisons should specify the actual GRF analog and attachment status before borrowing a structure or an experimental finding from another material carrying the CJC name.

Structure and research references: [1][2]

03 / Composition

What each vial holds.

Each vial holds the two peptides in equal amounts by mass, in the 5/5mg size.

CJC-1295 (No DAC) + Ipamorelin, per vial
VialCJC-1295 (No DAC)Ipamorelin
10mg5mg5mg
Amounts by mass, as formulated. Match your lot’s certificate to them.

04 / Read the evidence

Research & analytical context.

The reference structures distinguish a 29-residue modified GRF chain from a five-residue ipamorelin chain. Their sequences, terminal groups and molecular masses are separate specifications. A blend requires documentation of both, rather than a single combined sequence.

Read the references: [1][2][3][4][5].

The distinction that matters

No DAC is a meaningful identity distinction: do not borrow duration claims from DAC-containing CJC-1295. Equal milligrams of two peptides also do not mean equal numbers of molecules.

05 / From reference to record

Know the lot, too.

A publication describes its own test material. Your lot’s certificate describes what was tested on that lot. Keep the compound name, batch number and reported methods together when reviewing a result.

Identity & composition

Check sequence or chemical form, terminal modifications, counterion and—where relevant—each blend component.

Analytical results

Read purity, content, sterility and endotoxin results as separate measurements. Only call a test passed when the actual report supports it.

Handling & storage notes

Lyophilized material: Store at −20°C; protect from light and moisture.

Follow the material-specific label and supporting storage documentation. These temperatures do not establish a shelf life.

How to store lyophilized peptides

06 / Reference questions

A few details, explained.

Does this pairing form one 34-residue chain?

No. A formulation containing a 29-residue peptide and a five-residue peptide remains a mixture of separate molecules. Creating one covalently joined chain would describe a different chemical entity.

Are equal milligrams equal proportions of molecules?

Not necessarily. The two chains have different molecular masses. A mass ratio and a molar ratio express different properties, so a component breakdown in milligrams should not be relabeled as a molecule-count ratio.

Read alongside the references: [1][2]

07 / Continue reading

Go to the source.